James, G. ., Sanchez, J. J. G., Carrero, J. J., Kumar, S. ., Pecoits-Filho, R. ., Heerspink, H. J. L., … Wheeler, D. C. (2022). Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility. Kidney Int Rep, 7, 2059–2070. http://doi.org/10.1016/j.ekir.2022.05.033
H. Heerspink
First name
H.
Middle name
J. L.
Last name
Heerspink
Heerspink, H. J. L., Karasik, A. ., Thuresson, M. ., Melzer-Cohen, C. ., Chodick, G. ., Khunti, K. ., … Kosiborod, M. . (2020). Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study. Lancet Diabetes Endocrinol. http://doi.org/10.1016/s2213-8587(19)30384-5